Tags » Dyslipidemia

Evidence Lacking on Lipid Screening, the U.S. Preventive Services Task Force Concludes

In a recent review of the evidence base, the U.S. Preventive Services Task Force (USPSTF) concluded that current evidence is insufficient to recommend screening for lipid disorders in children and adolescents 20 years or younger. 190 more words

Childhood Obesity

Stress, Mindfulness and Mind-Full-Ness

Stress. Define it any way you wish but simply put, stress is the body’s reaction to any change that requires an adjustment or response. The unstressed state of the mind is called… 2,082 more words

Dr. Ahmed Hussain

Joint Program Family & Community Medicine, Jeddah – 2014

Background: Due to the tragic raises in the prevalence of both obesity and type 2 diabetes mellitus in Saudi Arabia, which are associated to changes in style of living associated with modernization and socioeconomic growth , adverse changes in the level of blood lipids are not unexpected. 377 more words

Pemafibrate

Pemafibrate

NDA Filing Japan, Phase 2 in EU, US

A PPAR-α agonist potentially for the treatment of dyslipidemia.

K-877, K-13675, (R)-

CAS No. 848259-27-8,

Molecular Formula,C28-H30-N2-O6,Molecular Weight,490.553… 1,310 more words

Phase2 Drugs

Allas al qhtani

Prince Sultan Medical Military City, Riyadh – 2014/2015

Dr. Khalid Al Gelban

National Guard Program    – Riyadh  2001/2002

The objective of the present work is to assess the ability of primary care physicians to apply correctly the recent hyperlipidemia management guidelines. 214 more words

Dr. Sharefa Al Anizi

National Guard Program    – Riyadh  2001/2002